Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Polton, G; Finotello, R; Sabattini, S; Rossi, F; Laganga, P; Vasconi, M E; Barbanera, A; Stiborova, K; Rohrer Bley, Carla; Marconato, L (2018). Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide. Veterinary and Comparative Oncology, 16(3):399-408.

Finotello, R; Stefanello, D; Zini, E; Marconato, L (2017). Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Veterinary and Comparative Oncology, 15(1):25-35.

Marconato, L; Finotello, R; Bonfanti, U; Dacasto, M; Beatrice, L; Pizzoni, S; Leone, V; Balestra, G; Furlanello, T; Rohrer Bley, C; Aresu, L (2015). An open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors. Journal of Veterinary Internal Medicine, 29(2):620-625.

Marconato, L; Crispino, G; Finotello, R; Mazzotti, S; Zini, E (2010). Clinical relevance of serial determinations of lactate dehydrogenase activity used to predict recurrence in dogs with lymphoma. Journal of the American Veterinary Medical Association, 236(9):969-974.

Marconato, L; Romanelli, G; Stefanello, D; Giacoboni, C; Bonfanti, U; Bettini, G; Finotello, R; Verganti, S; Valenti, P; Ciaramella, L; Zini, E (2009). Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008). Journal of the American Veterinary Medical Association, 235(8):967-972.

Marconato, L; Crispino, G; Finotello, R; Mazzotti, S; Salerni, F; Zini, E (2009). Serum lactate dehydrogenase activity in canine malignancies. Veterinary and Comparative Oncology, 7(4):236-243.

This list was generated on Sat Aug 24 03:01:22 2019 CEST.